A carregar...
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
OBJECTIVE: To examine the pricing trajectories in the United States of disease-modifying therapies (DMT) for multiple sclerosis (MS) over the last 20 years and assess the influences on rising prices. METHODS: We estimated the trend in annual drug costs for 9 DMTs using published drug pricing data fr...
Na minha lista:
| Publicado no: | Neurology |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4451044/ https://ncbi.nlm.nih.gov/pubmed/25911108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001608 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|